However, FDA rejected suggestions that low-risk devices be exempted because the cost of implementation will exceed the public health benefits gained.
There is no cost to implement that plan.
mnli hypothesis: There is no cost to implement that plan. premise: However, FDA rejected suggestions that low-risk devices be exempted because the cost of implementation will exceed the public health benefits gained.